JNJ

NYSE

JOHNSON & JOHNSON

Latest disclosureSeptember 10, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 11 sales

Price by TradingView

Insider transactions 47

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. No qualifying insider sales.

Showing the first 6 of 11 trades on this page.

Sale disclosed

Timothy Schmid

EVP, WW Chair, MedTech

Common Stock

Reported value: $3.04M
Reported price: $274.74 / share

Sale disclosed

Timothy Schmid

EVP, WW Chair, MedTech

Common Stock

Reported value: $6.19M
Reported price: $274.74 / share

Sale disclosed

Jennifer L. Taubert

EVP, WWC. Innovative Medicine

Common Stock

Reported value: $3.95M
Reported price: $263.36 / share

Sale disclosed

Joaquin Duato

CEO and Chairman of the Board

Common Stock

Reported value: $5.5M
Reported price: $262.00 / share

Sale disclosed

Joaquin Duato

CEO and Chairman of the Board

Common Stock

Reported value: $26.7M
Reported price: $261.00 / share

Sale disclosed

Joaquin Duato

CEO and Chairman of the Board

Common Stock

Reported value: $10.83M
Reported price: $258.056 / share

Sale disclosed

Joaquin Duato

CEO and Chairman of the Board

Common Stock

Reported value: $1.69M
Reported price: $258.739 / share

Sale disclosed

Elizabeth Forminard

EVP, Chief Legal Officer

Common Stock

Reported value: $2.41M
Reported price: $257.755 / share

Sale disclosed

Elizabeth Forminard

EVP, Chief Legal Officer

Common Stock

Reported value: $1.68M
Reported price: $255.932 / share

Sale disclosed

Vanessa Broadhurst

EVP, Global Corp Affairs

Common Stock

Reported value: $5.79M
Reported price: $251.266 / share

Sale disclosed

Kathryn E. Wengel

EVP, Chief TO and Risk Officer

Common Stock

Reported value: $2.41M
Reported price: $241.15 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
EVP, WW Chair, MedTech	Common StockSale2 trades	33,597avg $274.74 / share	$9.23M	Sep 2Filed Sep 4 · 2d later	2 filings 11,070 @ $274.74 · $3.04MSEC filing 22,527 @ $274.74 · $6.19MSEC filing
EVP, WWC. Innovative Medicine	Common StockSale	15,000$263.36 / share	$3.95M	Aug 17Filed Aug 18 · 1d later	SEC filing
CEO and Chairman of the Board	Common StockSale2 trades	123,291avg $261.17 / share	$32.2M	Aug 13Filed Aug 14 · 1d later	2 filings 20,976 @ $262.00 · $5.5MSEC filing 102,315 @ $261.00 · $26.7MSEC filing
CEO and Chairman of the Board	Common StockSale2 trades	48,480avg $258.15 / share	$12.52M	Aug 5Filed Aug 7 · 2d later	2 filings 41,957 @ $258.06 · $10.83MSEC filing 6,523 @ $258.74 · $1.69MSEC filing
EVP, Chief Legal Officer	Common StockSale2 trades	15,918avg $257.00 / share	$4.09M	Aug 6Filed Aug 7 · 1d later	2 filings 9,344 @ $257.76 · $2.41MSEC filing 6,574 @ $255.93 · $1.68MSEC filing
EVP, Global Corp Affairs	Common StockSale	23,054$251.27 / share	$5.79M	Jul 20Filed Jul 21 · 1d later	SEC filing
EVP, Chief TO and Risk Officer	Common StockSale	10,000$241.15 / share	$2.41M	Jun 11Filed Jun 12 · 1d later	SEC filing

Congress transactions 29

All Congress filings

Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Lloyd DoggettReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: September 8, 2026

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean JrReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 27, 2026

Partial sale disclosed

Johnson & Johnson Common Stock · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: August 20, 2026

Sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a sale for the member.

Richard Dean Dr McCormick official portrait

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 30, 2026

Full sale disclosedAmended report

Johnson & Johnson Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: October 29, 2024

Full sale disclosedAmended report

Johnson & Johnson Common Stock · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: October 29, 2024

Purchase disclosed

Johnson & Johnson Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 30, 2026

Purchase disclosed

Johnson & Johnson Common Stock · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean JrReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 29, 2026

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean JrReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 2, 2026

Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Lloyd DoggettReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: June 9, 2026

Partial sale disclosed

Johnson & Johnson Common Stock · Stock

The filing reports a partial sale for a joint account.

John BoozmanReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 19, 2026

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean JrReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 26, 2026

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 19, 2026

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 19, 2026

Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Lloyd DoggettReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 10, 2026

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean JrReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: January 23, 2026

Sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 18, 2025

Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Lloyd DoggettReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 9, 2025

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for the member.

Thomas H. Kean JrReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: November 20, 2025

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 13, 2025

Purchase disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a purchase for the member.

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 5, 2025

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for a dependent.

Jared MoskowitzReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 10, 2025

Partial sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a partial sale for a dependent.

Jared MoskowitzReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 10, 2025

Sale disclosed

Johnson & Johnson Common Stock (JNJ) · Stock

The filing reports a sale for a spouse.

Lisa McClainReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: October 31, 2025

Showing the latest 25 of 29 disclosed trades. Show all 29 trades

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000200406
Latest public acceptance: Sep 11, 2026, 12:51 AM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

EVP, WW Chair, MedTech

Common StockSale2 trades

33,597avg $274.74 / share

$9.23M

Sep 2Filed Sep 4 · 2d later

2 filings

11,070 @ $274.74 · $3.04MSEC filing
22,527 @ $274.74 · $6.19MSEC filing

EVP, WWC. Innovative Medicine

Common StockSale

15,000$263.36 / share

$3.95M

Aug 17Filed Aug 18 · 1d later

SEC filing

CEO and Chairman of the Board

Common StockSale2 trades

123,291avg $261.17 / share

$32.2M

Aug 13Filed Aug 14 · 1d later

2 filings

20,976 @ $262.00 · $5.5MSEC filing
102,315 @ $261.00 · $26.7MSEC filing

CEO and Chairman of the Board

Common StockSale2 trades

48,480avg $258.15 / share

$12.52M

Aug 5Filed Aug 7 · 2d later

2 filings

41,957 @ $258.06 · $10.83MSEC filing
6,523 @ $258.74 · $1.69MSEC filing

EVP, Chief Legal Officer

Common StockSale2 trades

15,918avg $257.00 / share

$4.09M

Aug 6Filed Aug 7 · 1d later

2 filings

9,344 @ $257.76 · $2.41MSEC filing
6,574 @ $255.93 · $1.68MSEC filing

EVP, Global Corp Affairs

Common StockSale

23,054$251.27 / share

$5.79M

Jul 20Filed Jul 21 · 1d later

SEC filing

EVP, Chief TO and Risk Officer

Common StockSale

10,000$241.15 / share

$2.41M

Jun 11Filed Jun 12 · 1d later

SEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0000200406
Latest public acceptance: Sep 11, 2026, 12:51 AM UTC
Score calculated: Oct 7, 2026, 12:04 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.